C0685000
Cefotaxime sodium
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 64485-93-4
Synonym(S): Cefotaxime sodium salt, Cefotaxim sodium salt
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 20 MG | C0685000-20-MG | In Stock | ₹ 16,107.60 |
C0685000 - 20 MG
In Stock
Quantity
1
Base Price: ₹ 16,107.60
GST (18%): ₹ 2,899.368
Total Price: ₹ 19,006.968
grade
pharmaceutical primary standard
API family
cefotaxime
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
[Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI
1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key
AZZMGZXNTDTSME-JUZDKLSSSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | TOKU-E Cefotaxime Sodium, USP, 64485-93-4, 1 g | TOKU-E | ₹ 9,497.16 | |
 | TOKU-E Cefotaxime Sodium, USP, 64485-93-4, 1 g | TOKU-E | ₹ 40,555.44 | |
 | Sigma Aldrich Fine Chemicals Biosciences Cefotaxime Sodium Salt | 64485-93-4 | MFCD00079073 | 1g | Sigma Aldrich Fine Chemicals Biosciences | ₹ 31,233.68 | |
 | Cefotaxime Sodium | Supelco | ₹ 16,616.38 | |
| | Cefotaxime sodium | Sigma Aldrich | ₹ 46,222.75 | |
| | Cefotaxime for peak identification | Sigma Aldrich | ₹ 14,267.35 | |
| | Cefotaxime sodium salt | Sigma Aldrich | ₹ 22,234.55 - ₹ 76,586.88 | |
| | Cefotaxime sodium salt | Sigma Aldrich | ₹ 6,170.25 - ₹ 1,90,649.90 | |
| | Cefotaxime sodium salt | Sigma Aldrich | ₹ 22,234.55 - ₹ 76,586.88 | |
 | 64485-93-4 | sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | A2B Chem | ₹ 1,454.52 - ₹ 56,555.16 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Cefotaxime sodium EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
- Biochem/physiol Actions: Cefotaxim inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) which inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls. As a result, bacteria lyse due to cell wall autolytic enzymes.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Broad spectrum third generation cephalosporin antibiotic.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P261 - P280 - P284 - P304 + P340 - P333 + P313 - P342 + P311
Hazard Classifications
Resp. Sens. 1 - Skin Sens. 1
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: cefotaxime
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: [Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI: 1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key: AZZMGZXNTDTSME-JUZDKLSSSA-M
grade:
pharmaceutical primary standard
API family:
cefotaxime
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
[Na+].[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\c3csc(N)n3)C([O-])=O
InChI:
1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI key:
AZZMGZXNTDTSME-JUZDKLSSSA-M
grade: pharmaceutical primary standard
API family: cefoxitin
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: [Na+].CO[C@]2(NC(=O)Cc1cccs1)C3SCC(COC(N)=O)=C(N3C2=O)C([O-])=O
InChI: 1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1
InChI key: GNWUOVJNSFPWDD-XMZRARIVSA-M
grade:
pharmaceutical primary standard
API family:
cefoxitin
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
[Na+].CO[C@]2(NC(=O)Cc1cccs1)C3SCC(COC(N)=O)=C(N3C2=O)C([O-])=O
InChI:
1S/C16H17N3O7S2.Na/c1-25-16(18-10(20)5-9-3-2-4-27-9)13(23)19-11(12(21)22)8(6-26-15(17)24)7-28-14(16)19;/h2-4,14H,5-7H2,1H3,(H2,17,24)(H,18,20)(H,21,22);/q;+1/p-1/t14-,16+;/m1./s1
InChI key:
GNWUOVJNSFPWDD-XMZRARIVSA-M
grade: pharmaceutical primary standard
API family: ceftazidime
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: __
InChI: 1S/C22H22N6O7S2.5H2O/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27;;;;;/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34);5*1H2/b26-13-;;;;;/t14-,18-;;;;;/m1...../s1
InChI key: NMVPEQXCMGEDNH-TZVUEUGBSA-N
grade:
pharmaceutical primary standard
API family:
ceftazidime
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
__
InChI:
1S/C22H22N6O7S2.5H2O/c1-22(2,20(33)34)35-26-13(12-10-37-21(23)24-12)16(29)25-14-17(30)28-15(19(31)32)11(9-36-18(14)28)8-27-6-4-3-5-7-27;;;;;/h3-7,10,14,18H,8-9H2,1-2H3,(H4-,23,24,25,29,31,32,33,34);5*1H2/b26-13-;;;;;/t14-,18-;;;;;/m1...../s1
InChI key:
NMVPEQXCMGEDNH-TZVUEUGBSA-N
grade: pharmaceutical primary standard
API family: ceftriaxone
manufacturer/tradename: EDQM
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: O.O.O.O.O.O.O.[Na+].[Na+].CO\N=C(/C(=O)N[C@H]1C2SCC(CSC3=NC(=O)C(=O)N([Na])N3C)=C(N2C1=O)C([O-])=O)c4csc(N)n4.CO\N=C(/C(=O)N[C@H]5C6SCC(CSC7=NC(=O)C(=O)N([Na])N7C)=C(N6C5=O)C([O-])=O)c8csc(N)n8
InChI: 1S/2C18H18N8O7S3.4Na.7H2O/c2*1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;;;;;;;;;/h2*5,9,15H,3-4H2,1-2H3,(H5,19,20,21,23,27,29,31,32);;;;;7*1H2/q;;4*+1;;;;;;;/p-4/b2*24-8-;;;;;;;;;;;/t2*9-,15-;;;;;;;;;;;/m11.........../s1
InChI key: PMRZKYOXTPBIQF-MAODNAKNSA-J
grade:
pharmaceutical primary standard
API family:
ceftriaxone
manufacturer/tradename:
EDQM
application(s):
pharmaceutical (small molecule)
format:
neat
SMILES string:
O.O.O.O.O.O.O.[Na+].[Na+].CO\N=C(/C(=O)N[C@H]1C2SCC(CSC3=NC(=O)C(=O)N([Na])N3C)=C(N2C1=O)C([O-])=O)c4csc(N)n4.CO\N=C(/C(=O)N[C@H]5C6SCC(CSC7=NC(=O)C(=O)N([Na])N7C)=C(N6C5=O)C([O-])=O)c8csc(N)n8
InChI:
1S/2C18H18N8O7S3.4Na.7H2O/c2*1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;;;;;;;;;/h2*5,9,15H,3-4H2,1-2H3,(H5,19,20,21,23,27,29,31,32);;;;;7*1H2/q;;4*+1;;;;;;;/p-4/b2*24-8-;;;;;;;;;;;/t2*9-,15-;;;;;;;;;;;/m11.........../s1
InChI key:
PMRZKYOXTPBIQF-MAODNAKNSA-J